Legend Biotech will host an investor conference call at 8:00 am ET on March 10, 2026, to review fourth-quarter and full-year 2025 results. Senior management will provide an overview during the call and webcast, accessible via weblink. The earnings press release and a replay will be available in the Investor Relations section under Events and Presentation approximately two hours after the call ends.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Legend Biotech Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202602240800PRIMZONEFULLFEED9659307) on February 24, 2026, and is solely responsible for the information contained therein.